Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Barnett Eva Renee
Chief Financial Officer at Immunovant. Filing since 7 Jan 2022.
CIK 0001883766
Company
Date
Role
Action
Shares
Amount
Of holding
IMVT
Immunovant, Inc.
16 Apr 2025
Chief Financial Officer
Sold at will
2,993
$44.57K
0.7%
IMVT
Immunovant, Inc.
9 Apr 2025
Chief Financial Officer
Sold at will
11,063
$143.71K
2.7%
IMVT
Immunovant, Inc.
19 Feb 2025
Chief Financial Officer
Sold at will
2,814
$58.70K
0.9%
IMVT
Immunovant, Inc.
15 Jan 2025
Chief Financial Officer
Sold at will
2,298
$54.76K
0.7%
IMVT
Immunovant, Inc.
8 Jan 2025
Chief Financial Officer
Sold at will
4,105
$98.93K
1.2%
IMVT
Immunovant, Inc.
20 Nov 2024
Chief Financial Officer
Sold at will
4,174
$106.23K
1.2%
IMVT
Immunovant, Inc.
16 Oct 2024
Chief Financial Officer
Sold at will
3,271
$94.17K
1.0%
IMVT
Immunovant, Inc.
9 Oct 2024
Chief Financial Officer
Sold at will
5,162
$152.59K
1.5%
IMVT
Immunovant, Inc.
21 Aug 2024
Chief Financial Officer
Sold at will
3,768
$120.04K
1.1%
IMVT
Immunovant, Inc.
17 Jul 2024
Chief Financial Officer
Sold at will
3,123
$92.73K
0.9%
IMVT
Immunovant, Inc.
9 Jul 2024
Chief Financial Officer
Sold at will
4,747
$133.20K
1.3%
IMVT
Immunovant, Inc.
22 May 2024
Chief Financial Officer
Sold at will
4,042
$119.85K
1.1%
IMVT
Immunovant, Inc.
17 Apr 2024
Chief Financial Officer
Sold at will
12,253
$356.05K
3.3%
IMVT
Immunovant, Inc.
9 Apr 2024
Chief Financial Officer
Sold at will
3,689
$115.02K
1.0%
IMVT
Immunovant, Inc.
22 Feb 2024
Chief Financial Officer
Sold at will
2,930
$105.92K
0.9%
IMVT
Immunovant, Inc.
11 Jan 2024
Chief Financial Officer
Sold at will
3,515
$147.02K
1.1%
IMVT
Immunovant, Inc.
22 Nov 2023
Chief Financial Officer
Sold at will
4,055
$132.92K
1.2%
IMVT
Immunovant, Inc.
10 Oct 2023
Chief Financial Officer
Sold at will
4,557
$168.24K
1.4%
IMVT
Immunovant, Inc.
24 Aug 2023
Chief Financial Officer
Sold at will
14,386
$292.04K
4.1%
IMVT
Immunovant, Inc.
19 Jul 2023
Chief Financial Officer
Sold at will
2,725
$67.96K
0.8%
IMVT
Immunovant, Inc.
18 Apr 2023
Chief Financial Officer
Sold at will
3,423
$52.27K
1.0%
IMVT
Immunovant, Inc.
11 Jan 2023
Chief Financial Officer
Sold, plan not stated
4,510
$75.52K
1.7%
IMVT
Immunovant, Inc.
11 Oct 2022
Chief Financial Officer
Sold, plan not stated
12,500
$118.00K
4.4%
IMVT
Immunovant, Inc.
7 Jan 2022
Chief Financial Officer
Sold, plan not stated
29,959
$217.20K
14.8%
24 decisions on file.
